Results 121 to 130 of about 9,019 (158)
Some of the next articles are maybe not open access.
Drugs, 1998
Telmisartan is a nonpeptide angiotensin II receptor antagonist which selectively and insurmountably inhibits the angiotensin II AT1 receptor subtype without affecting other receptor systems involved in cardiovascular regulation. Oral telmisartan dose-dependently reduced blood pressure (BP) in various animal models of hypertension.
K J, McClellan, A, Markham
+6 more sources
Telmisartan is a nonpeptide angiotensin II receptor antagonist which selectively and insurmountably inhibits the angiotensin II AT1 receptor subtype without affecting other receptor systems involved in cardiovascular regulation. Oral telmisartan dose-dependently reduced blood pressure (BP) in various animal models of hypertension.
K J, McClellan, A, Markham
+6 more sources
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan.
Journal of Clinical Oncology, 20109153 Background: We showed previously in 31 cancer patients (pts) that early cardiac abnormalities, i.e.
Dessi M +7 more
openaire +2 more sources
Drugs, 2001
Telmisartan is an angiotensin II receptor antagonist that is highly selective for type 1 angiotensin II receptors. It was significantly more effective than placebo in large (n >100), double-blind, randomised, multicentre clinical trials in patients with mild to moderate hypertension.
M, Sharpe, B, Jarvis, K L, Goa
openaire +2 more sources
Telmisartan is an angiotensin II receptor antagonist that is highly selective for type 1 angiotensin II receptors. It was significantly more effective than placebo in large (n >100), double-blind, randomised, multicentre clinical trials in patients with mild to moderate hypertension.
M, Sharpe, B, Jarvis, K L, Goa
openaire +2 more sources
Telmisartan in the treatment of hypertension
Expert Opinion on Drug Metabolism & Toxicology, 2008Telmisartan is an orally active angiotensin II receptor antagonist prescribed once daily.To evaluate the efficacy of telmisartan on blood pressure control, and on other end points, when given as monotherapy or in combination.Review of published literature.Telmisartan produces more effective control of blood pressure over 24 h, especially in the last 6 ...
Barbara H, Rosario +1 more
openaire +2 more sources